ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Condition : By Disease Heading : Rare Diseases : Osteosarcoma


Include trials that are no longer recruiting patients.

41 studies were found.
1.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors
Conditions: Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma; hematopoietic and lymphoid cancer; Neuroblastoma; Osteosarcoma
2.RecruitingAlanosine in Treating Patients With Cancer
Conditions: Gastrointestinal Cancer; musculoskeletal cancer; Osteosarcoma; thorax and respiratory cancer
3.RecruitingGenetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
Conditions: Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma; hematopoietic and lymphoid cancer; Osteosarcoma
4.RecruitingNeoadjuvant and Adjuvant Pamidronate With Induction and Maintenance Chemotherapy in Treating Patients With Osteosarcoma
Conditions: localized osteosarcoma; metastatic osteosarcoma
5.RecruitingInhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
Conditions: metastatic osteosarcoma; recurrent osteosarcoma; lung metastases
6.RecruitingGemcitabine and Docetaxel to Treat Bone and Soft Tissue Cancers
Conditions: Osteosarcoma; Sarcoma, Ewing's; Chondrosarcoma
7.RecruitingTemozolomide and O6-Benzylguanine for Treating Childhood Cancers
Conditions: Brain Neoplasm; Embryonal Neoplasm; Ewing's Sarcoma; Germ Cell Neoplasm; Liver Neoplasm; Nephroblastoma; Osteosarcoma; Rhabdomyosarcoma; Sarcoma
8.RecruitingBone Cancer: Treatment Outcome Based on Tumor Response
Condition: Osteosarcoma
9.RecruitingCombination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors
Conditions: childhood rhabdomyosarcoma; childhood soft tissue sarcoma; female reproductive cancer; Gastrointestinal Cancer; musculoskeletal cancer; Osteosarcoma
10.RecruitingIrinotecan in Treating Children With Refractory Solid Tumors
Conditions: Ewing's family of tumors; childhood brain tumor; childhood rhabdomyosarcoma; childhood solid tumor; Neuroblastoma; Osteosarcoma
11.RecruitingStudy of AP23573, an mTOR Inhibitor, in Patients with Advanced Sarcoma
Conditions: Leiomyosarcoma; Liposarcoma; Osteosarcoma; Sarcoma, Soft Tissue; Metastases
12.Not yet recruitingGemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma
Conditions: recurrent tumors of the Ewing's family; Chondrosarcoma; recurrent osteosarcoma
13.RecruitingChemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma
Condition: metastatic osteosarcoma
14.RecruitingCombination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma
Conditions: recurrent childhood acute lymphoblastic leukemia; recurrent childhood lymphoblastic lymphoma; recurrent osteosarcoma; ...
15.RecruitingEvaluation, Treatment, and Natural History of Children with Cancer
Conditions: Ewing's Sarcoma; Leukemia; Lymphoma; Neoplasm; Sarcoma
16.RecruitingHigh-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
Conditions: Breast Cancer; Gastrointestinal Cancer; Kidney Cancer; Musculoskeletal Cancer; Reproductive Cancer; Skin Cancer
17.Not yet recruitingCelecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer
Conditions: Cachexia; Cancer; Pain
18.RecruitingRadiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
Condition: Cancer
19.RecruitingErlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors
Condition: childhood cancer
20.RecruitingThalidomide and Docetaxel in Treating Patients With Advanced Cancer
Condition: Cancer
21.RecruitingABT-751 in Treating Young Patients With Refractory Solid Tumors
Condition: childhood cancer
22.RecruitingArsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
Condition: childhood cancer
23.RecruitingCombination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Condition: Cancer
24.Recruiting17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma
Condition: Cancer
25.Not yet recruitingWhole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma
Conditions: Ewing's family of tumors; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; childhood rhabdomyosarcoma; Neuroblastoma
26.Not yet recruitingEcteinascidin 743 in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
Conditions: recurrent childhood rhabdomyosarcoma; previously treated childhood rhabdomyosarcoma; recurrent childhood soft tissue sarcoma; ...
27.RecruitingStudying Genetic Changes in Ewing Sarcoma Tumors
Condition: Ewing's Sarcoma
28.RecruitingImatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor
Condition: recurrent tumors of the Ewing's family
29.RecruitingRadiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
Conditions: Ewing's family of tumors; adult solid tumor; childhood brain tumor; childhood solid tumor; Gastrointestinal Cancer; Neuroblastoma
30.RecruitingDiagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma
Conditions: localized tumors of the Ewing's family; metastatic tumors of the Ewing's family; recurrent tumors of the Ewing's family
31.RecruitingVincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) With or Without ImmTher for Newly Diagnosed High Risk Ewing's Sarcoma
Condition: Ewing's Sarcoma
32.RecruitingCombination Chemotherapy and Peripheral Stem Cell Transplantation With or Without Radiation Therapy and/or Surgery in Treating Patients With Ewing's Sarcoma
Conditions: localized tumors of the Ewing's family; metastatic tumors of the Ewing's family
33.RecruitingP-glycoprotein Antagonist, Tariquidar, in Combination with Doxorubicin (Adriamycin), Vinorelbine (Navelbine), or Docetaxel to Treat Children with Solid Tumors
Conditions: Brain Tumor; Ewing's Sarcoma; Neuroblastoma; Rhabdomyosarcoma
34.RecruitingComparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
Condition: localized tumors of the Ewing's family
35.RecruitingComparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts after Intensive Chemotherapy
Conditions: Ewing's Sarcoma; Rhabdomyosarcoma; Sarcoma; Synovial Sarcoma
36.RecruitingSurgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma
Conditions: Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma
37.RecruitingA Pilot Study of Autologous T-Cell Transplantation with Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas
Conditions: Ewing's Sarcoma; Rhabdomyosarcoma
38.Not yet recruitingOxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
Condition: Cancer
39.RecruitingCombination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma
Condition: adult soft tissue sarcoma
40.RecruitingCombination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
Conditions: bone marrow ablation; Cancer
41.RecruitingA Phase I Study of Single Agent OSI-774 (Tarceva) Followed by OSI-774 with Temozolomide for Patients with Selected Recurrent/Refractory Solid Tumors, Including Brain Tumors
Condition: Neoplasms

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act